Get the Stockscreener App
2.16
2.37%
0.05
Edesa Biotech Inc stock is traded at $2.16, with a volume of 3,925.
It is up +2.37% in the last 24 hours and up +3.35% over the past month.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
See More
Previous Close:
$2.11
Open:
$2.1301
24h Volume:
3,925
Relative Volume:
0.14
Market Cap:
$15.25M
Revenue:
-
Net Income/Loss:
$-7.72M
P/E Ratio:
-0.8184
EPS:
-2.6394
Net Cash Flow:
$-6.25M
1W Performance:
-4.42%
1M Performance:
+3.35%
6M Performance:
+16.13%
1Y Performance:
-53.15%
1-Day Range:
$2.13
$2.265
1-Week Range:
$2.0215
$2.265
52-Week Range:
$1.55
$5.00
Edesa Biotech Inc Stock (EDSA) Company Profile
Name
Edesa Biotech Inc
Sector
Industry
Phone
(905) 475-1234
Address
100 SPY COURT, MARKHAM, ON
Compare EDSA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EDSA
Edesa Biotech Inc
|
2.17 | 14.90M | 0 | -7.72M | -6.25M | -2.6394 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.76 | 93.98B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.35 | 59.67B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
430.15 | 57.53B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
644.11 | 40.50B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
289.43 | 34.26B | 3.81B | -644.79M | -669.77M | -6.24 |
Edesa Biotech Inc Stock (EDSA) Latest News
Edesa Biotech: A Narrowing Loss and Strategic Focus Signal Growing Momentum in Dermatology Innovation - AInvest
Can momentum traders help lift Edesa Biotech Inc.Trade Plan With Low Risk High Return - Newser
Real time alert setup for Edesa Biotech Inc. performanceBear Market Safe Zone Technical Analysis - Newser
Will Edesa Biotech Inc. stock go up soonStock Entry Point Planner with Volume Spike - Newser
Edesa Biotech Inc. Earnings Report Breakdown: What Investors Should KnowFree Value Investing Picks With Stability - Newser
How Resilient Is Edesa Biotech Inc. Stock During Economic DownturnsImmediate Entry Point Prediction Strategy - Newser
How to track smart money flows in Edesa Biotech Inc.Free High Yield Stock Screening Results - Newser
Edesa Biotech's Strategic Reorientation and Financial Resilience: A Path to Dermatology Sector Growth - AInvest
Edesa Biotech Advances Vitiligo Treatment Amidst Steady Financial Performance - TipRanks
Edesa Biotech Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Edesa Biotech Advances EB06 Manufacturing for Vitiligo Study, Reports Q3 2025 Results - AInvest
Edesa Biotech Q3 loss per share narrows - MarketScreener
Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results - GlobeNewswire
Edesa's New Vitiligo Drug Manufacturing Progress Signals Path to Phase 2 Trials as Q3 Financials Hold Steady - Stock Titan
Edesa Biotech Inc. stock chart pattern explainedDaily Stock Watch Summary with Key Insights - Newser
Edesa Biotech Inc. stock trend outlook and recovery pathPrice Action Summary and Entry Strategy Guide - Newser
How Edesa Biotech Inc. stock performs during market volatilityAI Screener for Daily Stock Forecast - Newser
Edesa Biotech EDSA 2025Q3 Earnings Preview Upside Potential on EPS Improvement - AInvest
Edesa Biotech Inc. Ranks High in Smart Money TrackerRisk Controlled Picks With Real Returns Outlined - beatles.ru
Edesa Biotech Inc. stock prediction for this weekDeep Stock Performance and Volatility Analysis - Newser
How many analysts rate Edesa Biotech Inc. as a “Buy”Unlock exclusive investment alerts - Jammu Links News
Should I hold or sell Edesa Biotech Inc. stock in 2025Invest confidently with professional guidance - Jammu Links News
What is the risk reward ratio of investing in Edesa Biotech Inc. stockMaximize your portfolio’s growth potential - Jammu Links News
How does Edesa Biotech Inc. generate profit in a changing economyHigh-yield market plays - Jammu Links News
What is the dividend policy of Edesa Biotech Inc. stockDiscover stocks with explosive growth potential - Jammu Links News
What are the latest earnings results for Edesa Biotech Inc.Phenomenal wealth increase - Jammu Links News
Is it the right time to buy Edesa Biotech Inc. stockFree Market Volatility Navigation Tips - Jammu Links News
Is Edesa Biotech Inc. stock overvalued or undervaluedMaximize gains with proven stock analysis - Jammu Links News
Is Edesa Biotech Inc. a growth stock or a value stockHigh-impact stock picks - Jammu Links News
How strong is Edesa Biotech Inc. company’s balance sheetPhenomenal trading returns - Jammu Links News
Why is Edesa Biotech Inc. stock attracting strong analyst attentionUnlock powerful market insights for success - Jammu Links News
What makes Edesa Biotech Inc. stock price move sharplyBuild wealth with proven stock investing tactics - Jammu Links News
How volatile is Edesa Biotech Inc. stock compared to the marketTrack emerging stocks with high growth potential - Jammu Links News
Is Edesa Biotech Inc. a good long term investmentInvest smarter with advanced market data - Jammu Links News
What catalysts could drive Edesa Biotech Inc. stock higher in 2025Unlock powerful stock screening tools - Jammu Links News
How sentiment analysis helps forecast Edesa Biotech Inc.Free Short Term Setup With Predictive Chart - Newser
Custom watchlist performance reports with Edesa Biotech Inc.Technical Insight Guide for Safer Trades - Newser
How hedge fund analytics apply to Edesa Biotech Inc. stockOversold Stock Bounce Playbook Generator - Newser
Edesa Biotech (EDSA) Expected to Announce Quarterly Earnings on Friday - Defense World
What institutional investors are buying Edesa Biotech Inc. stockDaily Trading Recommendation To Watch Now - Jammu Links News
Is Edesa Biotech Inc. stock entering bullish territoryRisk-Managed Trade Alerts for Consistency - Newser
Edesa Biotech Inc Stock (EDSA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.43%
8.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):